Newsroom

Sorted by: Latest
-

Securities Fraud Investigation Into Telesat Corporation (TSAT) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Telesat Corporation ("Telesat " or the Company") (NASDAQ: TSAT) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON TELESAT CORPORATION (TSAT), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On January 21, 2026, bondholders filed a lawsuit against Telesat...
-

Rosen Law Firm Encourages Nutanix, Inc. Investors to Inquire About Securities Class Action Investigation – NTNX

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of Nutanix, Inc. (NASDAQ: NTNX) resulting from allegations that Nutanix may have issued materially misleading business information to the investing public. So What: If you purchased Nutanix securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement....
-

GlobalAir.com Partners With AERO Friedrichshafen to Develop Pre-Owned Aircraft Area

LOUISVILLE, Ky.--(BUSINESS WIRE)--GlobalAir.com has been named the official sales representative for the pre-owned aircraft market at AERO Friedrichshafen....
-

A Concept Medical anuncia a inclusão do primeiro paciente no estudo clínico randomizado STARS DAPT, que avalia o stent farmacológico sem polímero Abluminus NP

TAMPA, Flórida--(BUSINESS WIRE)--A Concept Medical Inc., pioneira global em tecnologia inovadora de administração de medicamentos, tem o orgulho de anunciar a inclusão bem-sucedida do primeiro paciente no estudo clínico randomizado e controlado STARS DAPT (ST-Infarto do miocárdio com elevação do segmento ST tratado com um stent farmacológico sem polímero, com liberação de sirolimus por nanocarreador, e uma estratégia de terapia antiplaquetária única baseada em inibidor de P2Y12 após um curto pe...
-

Concept Medical inscribe los primeros pacientes en el ensayo clínico aleatorizado STARS DAPT, que evalúa el stent liberador de medicamentos sin polímeros Abluminus np

TAMPA, Florida--(BUSINESS WIRE)--Concept Medical Inc., pionera mundial en tecnología innovadora para la administración de medicamentos, se enorgullece de anunciar la incorporación satisfactoria de los primeros pacientes al estudio STARS DAPT ( ST -Segment Elevation Myocardial Inf A rction treated with a Polymer-Free Sirolimus-based Nanocarrie R Eluting Stent and a P2Y12 inhibitor-based S ingle Antiplatelet Strategy after a Short Dual Antiplatelet Therapy versus conventional D ual A nti P latele...
-

Samenvatting: Concept Medical kondigt de registratie aan van de eerste patiënten in de STARS DAPT gerandomiseerde klinische studie waarin Abluminus NP polymeervrije DES wordt beoordeeld

TAMPA, Fla.--(BUSINESS WIRE)--Concept Medical Inc., een wereldwijde pionier in innovatieve technologie voor toediening van geneesmiddelen, kondigt trots de succesvolle registratie aan van de eerste patiënten in de STARS DAPT ( ST -Segment Elevation Myocardial Inf A rction (= myocardinfarct met ST-segmentstijging) behandeld met een polymeervrije, op sirolimus gebaseerde nanocarrie R eluting stent en een op P2Y12 remmer gebaseerde S ingle Antiplatelet Strategie na een korte Dual Antiplatelet Ther...
-

Concept Medical kündigt die erste Patientenaufnahme in die randomisierte klinische Studie STARS DAPT zur Bewertung des Abluminus NP polymerefreien DES an

TAMPA, Florida--(BUSINESS WIRE)--Concept Medical Inc., ein globaler Pionier auf dem Gebiet innovativer Wirkstofffreisetzungstechnologien, freut sich, die erfolgreiche Aufnahme der ersten Patienten in die randomisierte kontrollierte STARS DAPT ( ST -Segment Elevation Myocardial Inf A rction treated with a Polymer-Free Sirolimus-based Nanocarrie R Eluting Stent and a P2Y12 inhibitor-based S ingle Antiplatelet Strategy after a Short Dual Antiplatelet Therapy versus conventional D ual A nti P latel...
-

Concept Medical annonce le recrutement du premier patient dans l'essai clinique randomisé STARS DAPT qui évalue l'Abluminus np, un DES sans polymère

TAMPA, Floride--(BUSINESS WIRE)--Concept Medical Inc., un pionnier mondial dans la technologie innovante d'administration de médicaments, est fier d'annoncer l'inscription des premiers patients dans l'essai contrôlé randomisé STARS DAPT ( ST -Segment Elevation Myocardial Inf A rction treated with a Polymer-Free Sirolimus-based Nanocarrie R Eluting Stent and a P2Y12 inhibitor-based S ingle Antiplatelet Strategy after a Short Dual Antiplatelet Therapy versus conventional D ual A nti P latelet T h...
-

Riassunto: Concept Medical annuncia l'arruolamento del primo paziente in STARS DAPT, il trial clinico randomizzato di valutazione del DES senza polimeri Abluminus NP

TAMPA, Fla.--(BUSINESS WIRE)--Concept Medical Inc., un pioniere globale nella tecnologia innovativa del rilascio di farmaci, è lieta di annunciare il reclutamento dei primi pazienti nello studio clinico randomizzato controllato STARS DAPT ( ST -Segment Elevation Myocardial Inf A rction treated with a Polymer-Free Sirolimus-based Nanocarrie R Eluting Stent and a P2Y12 inhibitor-based S ingle Antiplatelet Strategy after a Short Dual Antiplatelet Therapy versus conventional D ual A nti P latelet T...
-

コンセプト・メディカル、Abluminus NPポリマーフリーDESを評価するSTARS DAPT無作為化臨床試験で初の患者登録を達成

フロリダ州タンパ--(BUSINESS WIRE)--（ビジネスワイヤ） -- 革新的なドラッグデリバリー技術を手がける世界的なパイオニアであるコンセプト・メディカル（Concept Medical Inc.）は、無作為化比較試験「STARS DAPT（ ST -Segment Elevation Myocardial Inf A rction treated with a Polymer-Free Sirolimus-based Nanocarrie R Eluting Stent and a P2Y12 inhibitor-based S ingle Antiplatelet Strategy after a Short Dual Antiplatelet Therapy versus conventional D ual A nti P latelet T herapy）（ポリマーフリーのシロリムス系ナノキャリア溶出ステントで治療したST上昇型心筋梗塞（STEMI）患者を対象に、短期の抗血小板薬2剤併用療法後にP2Y12阻害薬を用いた単剤抗血小板療法と従来の抗血小板薬2剤併用療...